CEFIXIME is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Cefixime.
| Product ID | 68180-423_88f79e17-9a30-4025-9fdc-d1311d78e895 |
| NDC | 68180-423 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CEFIXIME |
| Generic Name | Cefixime |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-14 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA203195 |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | CEFIXIME |
| Active Ingredient Strength | 400 mg/1 |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-10-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 16714-766 | Cefixime | cefixime |
| 16714-767 | Cefixime | cefixime |
| 43598-673 | Cefixime | Cefixime |
| 43598-674 | Cefixime | Cefixime |
| 62250-663 | Cefixime | cefixime |
| 62250-664 | Cefixime | cefixime |
| 67877-584 | CEFIXIME | CEFIXIME |
| 68180-416 | CEFIXIME | CEFIXIME |
| 68180-405 | CEFIXIME | CEFIXIME |
| 68180-407 | CEFIXIME | CEFIXIME |
| 62250-668 | Cefixime | Cefixime |
| 65862-751 | Cefixime | Cefixime |
| 65862-752 | Cefixime | Cefixime |
| 68180-423 | CEFIXIME | CEFIXIME |
| 70518-2749 | CEFIXIME | CEFIXIME |
| 27437-201 | SUPRAX | cefixime |
| 27437-203 | SUPRAX | cefixime |
| 27437-205 | SUPRAX | cefixime |
| 27437-206 | SUPRAX | cefixime |
| 27437-207 | SUPRAX | cefixime |
| 27437-208 | SUPRAX | cefixime |
| 43063-537 | SUPRAX | cefixime |
| 54348-797 | SUPRAX | CEFIXIME |